Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study to determine if AZD2281 is effective and well tolerated in
maintaining the improvement in your cancer after previous platinum-based chemotherapy